Newsroom

News
10 July 2014

Kathleen Ford is named as new Chair

As the Pediatric Praziquantel Consortium moves into the clinical trial stage, the Consortium Board has appointed Mrs. Kathleen Ford, Head of Global Clinical...

Read more
News
10 July 2014

GHIT 1st Anniversary Event – progress to date

The 2014 decision by the Japanese Global Health Innovative Technology Fund (GHIT Fund) to support the Pediatric Praziquantel Consortium was a major...

Read more
News
10 July 2014

Preschoolers in Brazil

Dr. Otávio Pieri is a researcher at the Oswaldo Cruz Foundation, with a research focus on schistosomiasis. He explains what is happening in Brazil, and the...

Read more
News
10 July 2014

ERC consolidator grant winner

Prof. Jennifer Keiser of Swiss Tropical and Public Health Institute (Swiss TPH), partner at the Pediatric Praziquantel Consortium, received a prestigious ‘...

Read more
News
09 July 2014

Meet us at key conferences

09-07-2014

The Pediatric Praziquantel Consortium partners are committed to enhancing awareness, and helping overall global efforts towards...

Read more
Press release
28 March 2014

Pediatric Praziquantel Consortium awarded US$1.86 million GHIT grant

The Pediatric Praziquantel Consortium, launched in 2012 as an international non-profit public-private partnership, has announced that it has been awarded a...

Read more
Press release
25 March 2014

Pediatric Praziquantel Consortium expands into Brazil

Goal is to make treatment for schistosomiasis accessible to children under six years of age in endemic countries.

Read more
Press release
22 August 2013

International partnership receives funding to develop a drug product to fight schistosomiasis (bilharzia) in children

An international public-private partnership (PPP) was launched in July last year to develop a new pediatric formulation to combat schistosomiasis - commonly...

Read more
Press release
02 July 2012

New public-private partnership to develop a treatment for schistosomiasis-infected preschool children

A newly established international public-private partnership (PPP) between TI Pharma, Merck KGaA (Darmstadt, Germany), Astellas Pharma Inc. and the Swiss...

Read more

Pages